The V2 vasopressin receptor stimulates ERK1/2 activity independently of heterotrimeric G protein signalling

被引:60
|
作者
Charest, Pascale G.
Oligny-Longpre, Genevieve
Bonin, Helene
Azzi, Mounia
Bouvier, Michel
机构
[1] Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada
[2] Univ Montreal, Grp Rech Univ Med, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada
[3] Neurochem Inc, Laval, PQ H7V 4A7, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
V2 vasopressin receptor; GPCR; extra-cellular signal-regulated kinases 1 and 2; MAPK; beta arrestin;
D O I
10.1016/j.cellsig.2006.05.020
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The V2 vasopressin receptor (V2R) activates the mitogen activated protein kinases (MAPK) ERK 1/2 through a mechanism involving the scaffolding protein beta arrestin. Here we report that this activating pathway is independent of G alpha s, G alpha i, G alpha q or G beta alpha and that the V2R-mediated activation of G alpha s inhibits ERKI/2 activity in a cAMP/PKA-dependent manner. In the HEK293 cells studied, the beta arrestin-promoted activation was found to dominate over the PKA-mediated inhibition of the pathway, leading to a strong vasopressin-stimulated ERK1/2 activation. Despite the strong MAPK activation and in contrast with other GPCR, V2R did not induce any significant increase in DNA synthesis, consistent with the notion that the stable interaction between V2R and beta arrestin prevents signal propagation to the nucleus. beta arrestin was found to be essential for the ERK1/2 activation, indicating that the recruitment of the scaffolding protein is necessary and sufficient to initiate the signal in the absence of any other stimulatory cues. Based on the use of selective pharmacological inhibitors, dominant negative mutants and siRNA, we conclude that the beta arrestin-dependent activation of ERKI/2 by the V2R involves c-Src and a metalloprotemase-dependent trans-activation event. These findings demonstrate that beta arrestin is a genuine signalling initiator\that can, on its own, engage a MAPK activation machinery upon stimulation of a GPCR by its natural ligand. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:32 / 41
页数:10
相关论文
共 50 条
  • [21] Degradation of V2 vasopressin receptor mutants
    Schwieger, I
    Lautz, K
    Wiesner, B
    Hermosilla, R
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2006, 372 : 33 - 33
  • [22] Vasopressin V2 receptor/bioligand interactions
    Czaplewski, C
    Kazmierkiewicz, R
    Ciarkowski, J
    LETTERS IN PEPTIDE SCIENCE, 1998, 5 (5-6): : 333 - 335
  • [23] Vasopressin V2 receptor/bioligand interactions
    Cezary Czaplewski
    Rajmund Kaźmierkiewicz
    Jerzy Ciarkowski
    Letters in Peptide Science, 1998, 5 : 333 - 335
  • [24] Bridged bicyclic vasopressin receptor antagonists V2-selective or dual V1a/V2 activity
    Dyatkin, AB
    Hoekstra, WJ
    Hlasta, DJ
    Andrade-Gordon, P
    de Garavilla, L
    Demarest, KT
    Gunnet, JW
    Hagemann, W
    Look, R
    Maryanoff, BE
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (21) : 3081 - 3084
  • [25] Conivaptan:: A dual receptor vasopressin V1a/V2 antagonist
    Ali, Farhan
    Raufi, M. Adnan
    Washington, Barbara
    Ghali, Jalal K.
    CARDIOVASCULAR DRUG REVIEWS, 2007, 25 (03): : 261 - 279
  • [26] Different G protein-coupled receptor kinases govern G protein and β-arrestin-mediated signaling of V2 vasopressin receptor
    Ren, XR
    Reiter, E
    Ahn, S
    Kim, J
    Chen, W
    Lefkowitz, RJ
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (05) : 1448 - 1453
  • [27] Regulator of G protein signalling 14 attenuates cardiac remodelling through the MEK–ERK1/2 signalling pathway
    Ying Li
    Xiao-hong Tang
    Xiao-hui Li
    Hai-jiang Dai
    Ru-jia Miao
    Jing-jing Cai
    Zhi-jun Huang
    Alex F. Chen
    Xiao-wei Xing
    Yao Lu
    Hong Yuan
    Basic Research in Cardiology, 2016, 111
  • [28] Stress induces the expression of heterotrimeric G protein β subunits and the phosphorylation of PKB/Akt and ERK1/2 in rat brain
    Lee, Seok Yong
    Kang, Jong Seong
    Song, Gyu Yong
    Myung, Chang-Seon
    NEUROSCIENCE RESEARCH, 2006, 56 (02) : 180 - 192
  • [29] REGULATION OF VASOPRESSIN V2 RECEPTOR PROTEIN EXPRESSION IN RAT-KIDNEY
    DIGIOVANNI, SR
    ECELBARGER, C
    TERRIS, J
    KNEPPER, MA
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 320 - 320
  • [30] Use of the green fluorescent protein to study the intracellular transport of the G protein-coupled vasopressin V2 receptor
    Schülein, R
    Oksche, A
    Hermosilla, R
    Rosenthal, W
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 357 (04) : R55 - R55